Related Experiment Video
Updated: Aug 23, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
Dmitry Victorovich Garbuzenko1
1Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russia.
Insights
Non-alcoholic fatty liver disease (NAFLD) is linked to cardiovascular disease. Understanding NAFLD
Area of Science:
- Hepatology and Cardiology
- Metabolic Syndrome Research
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a prevalent global liver condition.
- Cardiovascular disease (CVD) is the leading cause of mortality in NAFLD patients.
- Shared lifestyle factors like poor nutrition and inactivity contribute to both NAFLD and CVD.
Purpose of the Study:
- To review and elucidate the potential pathophysiological mechanisms linking NAFLD and CVD.
- To explore how understanding these mechanisms can improve therapeutic strategies.
Main Methods:
- Comprehensive literature search of PubMed, EMBASE, Google Scholar, and Cochrane Library (2006-2022).
- Keywords: "Non-alcoholic fatty liver disease," "Cardiovascular diseases," "Pathophysiological mechanisms."
- Reference list screening of identified articles for additional relevant studies.
Main Results:
- Pathophysiological links between NAFLD and CVD are largely speculative.
- Potential mechanisms include systemic inflammation, atherogenic dyslipidemia, impaired glucose metabolism, hepatic insulin resistance, endothelial dysfunction, and gut dysbiosis.
- Cardiac remodeling influenced by genetic and epigenetic factors is also implicated.
Conclusions:
- Identifying the precise pathophysiological mechanisms is crucial for effective NAFLD-associated CVD treatment.
- Further research into these mechanisms may lead to more targeted and optimal therapeutic interventions.
Abstract:
Non-alcoholic fatty liver disease is one of the main liver diseases worldwide. The most common cause of death in patients with non-alcoholic fatty liver disease is cardiovascular disease. The relationship between these two conditions has been well established. Indeed, identical reasons may contribute to the development of cardiovascular disease and non-alcoholic fatty liver disease with lifestyle factors such as smoking, sedentariness, poor nutritional habits, and physical inactivity being major aspects. This review focuses on potential pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver. PubMed, EMBASE, Orphanet, MIDLINE, Google Scholar, and Cochrane Library were searched for articles published between 2006 and 2022. Relevant articles were selected using the following terms: "Non-alcoholic fatty liver disease," "Сardiovascular diseases," "Pathophysiological mechanisms." The reference lists of all identified articles were searched for other relevant publications as well. The pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver remain largely speculative and may include systemic low-grade inflammation, atherogenic dyslipidemia, abnormal glucose metabolism and hepatic insulin resistance, endothelial dysfunction, gut dysbiosis, as well as the associated cardiac remodeling, which are influenced by interindividual genetic and epigenetic variations. It is clear that the identification of pathophysiological mechanisms underlying cardiovascular disorders in non-alcoholic fatty liver disease will make the selection of therapeutic measures more optimal and effective.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease II: Pathophysiology
Pathophysiology of Heart Failure
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...